Investigation launched into Select Medical buyout for possibly undervaluing shares

Scott+Scott Attorneys at Law LLP has started an investigation into whether Select Medical Holdings' officers and directors approved a buyout at $16.50 per share that may have undervalued the company, potentially harming shareholders. The buyout is led by Select Medical's CEO, Executive VP, and a private equity firm. Shareholders are encouraged to contact the law firm to learn about their rights and possibly join the investigation. This probe could impact shareholder recoveries and corporate governance practices at Select Medical.